Qiagen N.V. | Mutual Funds
Mutual Funds that own Qiagen N.V.
Vanguard Capital Opportunity Fund
7,147,500
3.16%
-3,000
1.48%
06/30/2018
PRIMECAP Odyssey Aggressive Growth Fund
3,935,568
1.74%
-200,005
1.36%
06/30/2018
iShares TecDAX (DE)
3,213,424
1.42%
0
10.23%
09/07/2018
Templeton Foreign Fund
3,140,291
1.39%
0
1.81%
03/31/2018
Vanguard Total International Stock Index Fund
3,121,932
1.38%
56,826
0.03%
07/31/2018
PRIMECAP Odyssey Growth Fund
2,917,961
1.29%
0
0.84%
06/30/2018
Sycomore Partners Fund
2,701,111
1.19%
577,778
3.83%
09/30/2016
Templeton Growth Fund
2,046,810
0.9%
0
0.56%
12/31/2017
First Trust NYSE Arca Biotechnology Index Fund
2,005,384
0.89%
0
3.37%
09/05/2018
MFS Institutional International Equity Fund
1,934,529
0.85%
-3,975
0.75%
07/31/2018
| Address |
Hulsterweg 82
Venlo Limburg 5912 PL
Netherlands
|
|
Employees
|
- |
| Website |
http://www.qiagen.com |
| Updated |
07/08/2019 |
| QIAGEN NV is a holding company, which engages in the manufacture and distribution of sample and assay technology products for preanalytical sample preparations. It provides solutions to customers that are classified into molecular diagnostics, applied testing, pharma, and academia. Its products include instruments, and consumables and related products. |
